J. Brandon Parker

2.7k citations

37 papers · 1.9k indexed · 1 hit paper · h-index 24

Co-authors: Debabrata Chakravarti Michael McMillian Mark D. Johnson Angelique M. Leone Irina M. Bochkis John Brestelli Phillip Le Todd S. Macfarlan
Topics: Genomics and Chromatin Dynamics (6 papers)Uterine Myomas and Treatments (6 papers)Pharmacogenetics and Drug Metabolism (5 papers)
Cited by: Pharmacology Molecular Biology Cancer Research
Journals: Journal of Biological Chemistry Nature Communications Physiological Reviews
Partner nations: United States Germany Japan

In The Last Decade

J. Brandon Parker

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy

2019 302 citations Huiying Han, Atul D. Jain et al. Cancer Cell profile →

Peers

Countries citing papers authored by J. Brandon Parker

Since Specialization

Citations

This map shows the geographic impact of J. Brandon Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Brandon Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Brandon Parker more than expected).

Fields of papers citing papers by J. Brandon Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Brandon Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Brandon Parker. The network helps show where J. Brandon Parker may publish in the future.

Co-authorship network of co-authors of J. Brandon Parker

This figure shows the co-authorship network connecting the top 25 collaborators of J. Brandon Parker. A scholar is included among the top collaborators of J. Brandon Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Brandon Parker. J. Brandon Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitors 2025 ·Science Advances ·William Y. Yang,Qianyu Guo,(unknown),Zachary R. Chalmers,J. Brandon Parker,Mihai I. Truica,(unknown),(unknown),Karthik Vasan,(unknown),(unknown),Hao Pan,(unknown),(unknown),(unknown),Hoang Tran Pham,Gary E. Schiltz,Debabrata Chakravarti,Navdeep S. Chandel,Sarki A. Abdulkadir	0
2	Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype 2024 ·PubMed ·(unknown),(unknown),Jian‐Jun Wei,J. Brandon Parker,Debabrata Chakravarti	1
3	A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression 2022 ·Science Advances ·(unknown),J. Brandon Parker,Vinay Sagar,Mihai I. Truica,(unknown),Huiying Han,Gary E. Schiltz,Sarki A. Abdulkadir,Debabrata Chakravarti	37
4	Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution 2021 ·Cell Reports ·(unknown),(unknown),Christopher R. Futtner,Miroslav Hejna,(unknown),(unknown),Poorva Sandlesh,Magdy P. Milad,Jian‐Jun Wei,Serdar E. Bulun,J. Brandon Parker,Grant D. Barish,Jun S. Song,Debabrata Chakravarti	14
5	Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas 2020 ·Nature Communications ·(unknown),J. Brandon Parker,Debabrata Chakravarti	37
6	Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapybreakdown → 2019 ·Cancer Cell ·Huiying Han,Atul D. Jain,Mihai I. Truica,(unknown),Jonathan F. Anker,Barbara Lysy,Vinay Sagar,Yi Luan,Zachary R. Chalmers,Kenji Unno,Hanlin Mok,Rajita Vatapalli,Young A. Yoo,Yara Rodríguez,Irawati Kandela,J. Brandon Parker,Debabrata Chakravarti,Rama K. Mishra,Gary E. Schiltz,Sarki A. Abdulkadir	302
7	Decreased expression of microRNA-29 family in leiomyoma contributes to increased major fibrillar collagen production 2016 ·Fertility and Sterility ·Erica E. Marsh,(unknown),J. Brandon Parker,(unknown),Debabrata Chakravarti,Serdar E. Bulun	36
8	Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells 2014 ·Oncogene ·I. Moy,Viktor Todorović,Adi D. Dubash,John S. Coon,J. Brandon Parker,(unknown),(unknown),Hong Zhao,(unknown),Serdar E. Bulun	20
9	Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants 2014 ·Toxicology and Applied Pharmacology ·Angelique M. Leone,Alex Nie,J. Brandon Parker,Sharmilee P. Sawant,(unknown),Michael F. Kelley,(unknown),(unknown),Geert R. Verheyen,Mark D. Johnson,Peter G. Lord,Michael McMillian	37
10	Host Cell Factor-1 Recruitment to E2F-Bound and Cell-Cycle-Control Genes Is Mediated by THAP11 and ZNF143 2014 ·Cell Reports ·J. Brandon Parker,Hanwei Yin,(unknown),Debabrata Chakravarti	42
11	Transforming growth factor beta upregulates collagen via the suppression of microrna-29 expression in leiomyoma 2012 ·Fertility and Sterility ·Erica E. Marsh,J. Brandon Parker,Jinxiang Wu,(unknown),(unknown),S.E. Bulun	1
12	Chromatin Binding of SRp20 and ASF/SF2 and Dissociation from Mitotic Chromosomes Is Modulated by Histone H3 Serine 10 Phosphorylation 2009 ·Molecular Cell ·Rebecca J. Loomis,Yoshinori Naoe,J. Brandon Parker,Velibor Savic,(unknown),Todd S. Macfarlan,James L. Manley,Debabrata Chakravarti	147
13	Glucocorticoid Receptor-Dependent Gene Regulatory Networks 2005 ·PLoS Genetics ·Phillip Le,Joshua R. Friedman,Jonathan Schug,John Brestelli,J. Brandon Parker,Irina M. Bochkis,Klaus H. Kaestner	192
14	Thanatos-Associated Protein 7 Associates with Template Activating Factor-Iβ and Inhibits Histone Acetylation to Repress Transcription 2005 ·Molecular Endocrinology ·Todd S. Macfarlan,J. Brandon Parker,Kyosuke Nagata,Debabrata Chakravarti	35
15	Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver 2004 ·Biochemical Pharmacology ·Michael McMillian,Alex Nie,J. Brandon Parker,Angelique M. Leone,(unknown),Stewart Bryant,(unknown),Lynn Yieh,Anton Bittner,Xuejun Liu,Jackson Wan,Mark D. Johnson	43
16	A gene expression signature for oxidant stress/reactive metabolites in rat liver 2004 ·Biochemical Pharmacology ·Michael McMillian,Alex Nie,J. Brandon Parker,Angelique M. Leone,Stewart Bryant,(unknown),(unknown),Yanhong Liu,Lynn Yieh,Anton Bittner,Xuejun Liu,Jackson Wan,Mark D. Johnson	64
17	Retinoic acid treated HL60 cells express CEACAM1 (CD66a) and phagocytoseNeisseria gonorrhoeae 2004 ·FEMS Immunology & Medical Microbiology ·(unknown),Inês Chen,J. Brandon Parker,Pei Zhang,Fritz Grunert,Tie Chen	16
18	Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes 2003 ·Biochemical Pharmacology ·Dirk Roymans,(unknown),Angelique M. Leone,J. Brandon Parker,Michael McMillian,Mark D. Johnson,Aruna Koganti,Ron Gilissen,Paul M. Silber,Geert Mannens,W. Meuldermans	57
19	An improved resazurin-based cytotoxicity assay for hepatic cells 2002 ·Cell Biology and Toxicology ·Michael McMillian,(unknown),J. Brandon Parker,Leena Patel,Zhiqiang Zhong,(unknown),William J. Powers,Mark D. Johnson	89
20	Nile Red Binding to HepG2 Cells: An Improved Assay for In Vitro Studies of Hepatosteatosis 2001 ·PubMed ·Michael McMillian,Elfrida R. Grant,Zhong Zhong,J. Brandon Parker,Li Li,Robert A. Zivin,Michael E. Burczynski,Mark D. Johnson	94

About J. Brandon Parker

J. Brandon Parker is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pharmacology, having authored 37 papers that have together received 1.9k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (6 papers), Uterine Myomas and Treatments (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Pharmacology (186 citations), Molecular Biology (1.0k citations) and Cancer Research (227 citations). J. Brandon Parker has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Debabrata Chakravarti, Michael McMillian, Mark D. Johnson, Angelique M. Leone, Irina M. Bochkis, John Brestelli, Phillip Le, Todd S. Macfarlan, Jonathan Schug and Joshua R. Friedman. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Physiological Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact